Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Junko Koiwa"'
Publikováno v:
Pharmaceuticals, Vol 17, Iss 1, p 82 (2024)
Isoniazid is a first-line drug in antitubercular therapy. Isoniazid is one of the most commonly used drugs that can cause liver injury or acute liver failure, leading to death or emergency liver transplantation. Therapeutic approaches for the prevent
Externí odkaz:
https://doaj.org/article/00300a45eabd413aa9a0d62689e2cf3c
Autor:
Aina Higuchi, Eri Wakai, Tomoko Tada, Junko Koiwa, Yuka Adachi, Takashi Shiromizu, Hidemasa Goto, Toshio Tanaka, Yuhei Nishimura
Publikováno v:
Pharmaceuticals, Vol 14, Iss 11, p 1117 (2021)
Hepatic apoptosis is involved in a variety of pathophysiologic conditions in the liver, including hepatitis, steatosis, and drug-induced liver injury. The development of easy-to-perform and reliable in vivo assays would thus greatly enhance the effor
Externí odkaz:
https://doaj.org/article/31971d8532744cd389bcecf1fb492e2b
Autor:
Junko Koiwa, Takashi Shiromizu, Yuka Adachi, Makoto Ikejiri, Kaname Nakatani, Toshio Tanaka, Yuhei Nishimura
Publikováno v:
Pharmaceuticals, Vol 12, Iss 4, p 145 (2019)
The developing brain is extremely sensitive to many chemicals. Exposure to neurotoxicants during development has been implicated in various neuropsychiatric and neurological disorders, including autism spectrum disorders and schizophrenia. Various sc
Externí odkaz:
https://doaj.org/article/1efdaa2202ca403792b6924a593f30db
Publikováno v:
Congenital Anomalies. 62:27-37
Palatogenesis is affected by many factors, including gene polymorphisms and exposure to toxic chemicals during sensitive developmental periods. Cleft palate is one of the most common congenital anomalies, and ongoing efforts to elucidate the molecula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df301c1743da111e760e1537329ea533
https://doi.org/10.1111/cga.12451
https://doi.org/10.1111/cga.12451
Autor:
Eri Wakai, Toshio Tanaka, Yuka Adachi, Aina Higuchi, Junko Koiwa, Tomoko Tada, Takashi Shiromizu, Hidemasa Goto, Yuhei Nishimura
Publikováno v:
Pharmaceuticals
Volume 14
Issue 11
Pharmaceuticals, Vol 14, Iss 1117, p 1117 (2021)
Volume 14
Issue 11
Pharmaceuticals, Vol 14, Iss 1117, p 1117 (2021)
Hepatic apoptosis is involved in a variety of pathophysiologic conditions in the liver, including hepatitis, steatosis, and drug-induced liver injury. The development of easy-to-perform and reliable in vivo assays would thus greatly enhance the effor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8096cb8bd3a0a2bc139107ea7640c4c7
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 96:3-B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a66300c5fc8d4240883b1d1f533db7b8
https://doi.org/10.1254/jpssuppl.96.0_3-b-p-228
https://doi.org/10.1254/jpssuppl.96.0_3-b-p-228
Autor:
Mayuko Okuno, Junko Koiwa, Naohisa Kuriyama, Ikuko Mikami, Shota Sasagawa, Erina Kitahara, Aiko Sugimura, Yuka Takahashi, Toshio Tanaka, Shuji Isaji
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO4-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c2946fec98869d27404f93059318bce
https://doi.org/10.1254/jpssuppl.wcp2018.0_po4-10-25
https://doi.org/10.1254/jpssuppl.wcp2018.0_po4-10-25
Autor:
Kaname Nakatani, Takashi Shiromizu, Toshio Tanaka, Makoto Ikejiri, Yuhei Nishimura, Yuka Adachi, Junko Koiwa
Publikováno v:
Pharmaceuticals, Vol 12, Iss 4, p 145 (2019)
Pharmaceuticals
Volume 12
Issue 4
Pharmaceuticals
Volume 12
Issue 4
The developing brain is extremely sensitive to many chemicals. Exposure to neurotoxicants during development has been implicated in various neuropsychiatric and neurological disorders, including autism spectrum disorders and schizophrenia. Various sc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a20293647e5f7eb84290994ddfdaf20
https://www.mdpi.com/1424-8247/12/4/145
https://www.mdpi.com/1424-8247/12/4/145
Autor:
Toshio Tanaka, Junko Koiwa
Publikováno v:
Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 154(2)
Even after entering the era of genomic drug discovery in the 21st century, development of a breakthrough therapeutic drug (first-in-class) for intractable diseases (unmet medical needs) has been extremely difficult, but to the US FDA 62% of the appro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceac37fd5734be1e2fe40b5f076b56e2
https://pubmed.ncbi.nlm.nih.gov/31406047
https://pubmed.ncbi.nlm.nih.gov/31406047
Autor:
Yuka Adachi, Yuhei Nishimura, Eri Wakai, Tomoko Tada, Toshio Tanaka, Takashi Shiromizu, Aina Higuchi, Junko Koiwa
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. 94:1-O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75d9db63c334b2d735f21b2925300962
https://doi.org/10.1254/jpssuppl.94.0_1-o-g1-1
https://doi.org/10.1254/jpssuppl.94.0_1-o-g1-1